Updated consensus statement on biological agents, specifically tumour necrosis factor α (TNFα) blocking agents and interleukin-1 receptor antagonist (IL-1 ra), for the treatment of rheumatic diseases, 2004

D. E. Furst; F. C. Breedveld; J. R. Kalden; J. S. Smolen; G. R. Burmester; J. W. J. Bijlsma; M. Dougados; P. Emery; E. C. Keystone; L. Klareskog; P. J. Mease

doi:10.1136/ard.2004.029272

Updated consensus statement on biological agents, specifically tumour necrosis factor α (TNFα) blocking agents and interleukin-1 receptor antagonist (IL-1 ra), for the treatment of rheumatic diseases, 2004

D. E. Furst^*, F. C. Breedveld, J. R. Kalden, J. S. Smolen, G. R. Burmester, J. W. J. Bijlsma, M. Dougados, P. Emery, E. C. Keystone, L. Klareskog, P. J. Mease

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

79 Citations (Scopus)

Original language	English
Journal	Annals of the rheumatic diseases
Volume	63
Issue number	SUPPL. 2
DOIs	https://doi.org/10.1136/ard.2004.029272
Publication status	Published - Nov 2004
Externally published	Yes

Access to Document

10.1136/ard.2004.029272

Cite this

Furst, D. E., Breedveld, F. C., Kalden, J. R., Smolen, J. S., Burmester, G. R., Bijlsma, J. W. J., Dougados, M., Emery, P., Keystone, E. C., Klareskog, L., & Mease, P. J. (2004). Updated consensus statement on biological agents, specifically tumour necrosis factor α (TNFα) blocking agents and interleukin-1 receptor antagonist (IL-1 ra), for the treatment of rheumatic diseases, 2004. Annals of the rheumatic diseases, 63(SUPPL. 2). https://doi.org/10.1136/ard.2004.029272

@article{c25b5544e0054080b91197717f4979fb,

title = "Updated consensus statement on biological agents, specifically tumour necrosis factor α (TNFα) blocking agents and interleukin-1 receptor antagonist (IL-1 ra), for the treatment of rheumatic diseases, 2004",

author = "Furst, {D. E.} and Breedveld, {F. C.} and Kalden, {J. R.} and Smolen, {J. S.} and Burmester, {G. R.} and Bijlsma, {J. W. J.} and M. Dougados and P. Emery and Keystone, {E. C.} and L. Klareskog and Mease, {P. J.}",

year = "2004",

month = nov,

doi = "10.1136/ard.2004.029272",

language = "English",

volume = "63",

journal = "Annals of the rheumatic diseases",

issn = "0003-4967",

publisher = "BMJ Publishing Group",

number = "SUPPL. 2",

}

Furst, DE, Breedveld, FC, Kalden, JR, Smolen, JS, Burmester, GR, Bijlsma, JWJ, Dougados, M, Emery, P, Keystone, EC, Klareskog, L & Mease, PJ 2004, 'Updated consensus statement on biological agents, specifically tumour necrosis factor α (TNFα) blocking agents and interleukin-1 receptor antagonist (IL-1 ra), for the treatment of rheumatic diseases, 2004', Annals of the rheumatic diseases, vol. 63, no. SUPPL. 2. https://doi.org/10.1136/ard.2004.029272

Updated consensus statement on biological agents, specifically tumour necrosis factor α (TNFα) blocking agents and interleukin-1 receptor antagonist (IL-1 ra), for the treatment of rheumatic diseases, 2004. / Furst, D. E.; Breedveld, F. C.; Kalden, J. R. et al.
In: Annals of the rheumatic diseases, Vol. 63, No. SUPPL. 2, 11.2004.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Updated consensus statement on biological agents, specifically tumour necrosis factor α (TNFα) blocking agents and interleukin-1 receptor antagonist (IL-1 ra), for the treatment of rheumatic diseases, 2004

AU - Furst, D. E.

AU - Breedveld, F. C.

AU - Kalden, J. R.

AU - Smolen, J. S.

AU - Burmester, G. R.

AU - Bijlsma, J. W. J.

AU - Dougados, M.

AU - Emery, P.

AU - Keystone, E. C.

AU - Klareskog, L.

AU - Mease, P. J.

PY - 2004/11

Y1 - 2004/11

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=7044227564&origin=inward

UR - https://www.ncbi.nlm.nih.gov/pubmed/15479866

U2 - 10.1136/ard.2004.029272

DO - 10.1136/ard.2004.029272

M3 - Article

C2 - 15479866

SN - 0003-4967

VL - 63

JO - Annals of the rheumatic diseases

JF - Annals of the rheumatic diseases

IS - SUPPL. 2

ER -

Furst DE, Breedveld FC, Kalden JR, Smolen JS, Burmester GR, Bijlsma JWJ et al. Updated consensus statement on biological agents, specifically tumour necrosis factor α (TNFα) blocking agents and interleukin-1 receptor antagonist (IL-1 ra), for the treatment of rheumatic diseases, 2004. Annals of the rheumatic diseases. 2004 Nov;63(SUPPL. 2). doi: 10.1136/ard.2004.029272

Updated consensus statement on biological agents, specifically tumour necrosis factor α (TNFα) blocking agents and interleukin-1 receptor antagonist (IL-1 ra), for the treatment of rheumatic diseases, 2004

Access to Document

Other files and links

Cite this